Readystate Asset Management LP cut its holdings in BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report) by 95.9% in the first quarter, Holdings Channel reports. The fund owned 13,236 shares of the company’s stock after selling 308,023 shares during the quarter. Readystate Asset Management LP’s holdings in BlackRock Health Sciences Term Trust were worth $190,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Kestra Advisory Services LLC bought a new stake in shares of BlackRock Health Sciences Term Trust in the 4th quarter valued at about $26,000. SouthState Bank Corp purchased a new stake in shares of BlackRock Health Sciences Term Trust in the 1st quarter worth approximately $29,000. PNC Financial Services Group Inc. bought a new position in shares of BlackRock Health Sciences Term Trust during the first quarter valued at approximately $35,000. Geneos Wealth Management Inc. bought a new position in shares of BlackRock Health Sciences Term Trust during the first quarter valued at approximately $40,000. Finally, Allworth Financial LP increased its holdings in BlackRock Health Sciences Term Trust by 24,584.6% during the third quarter. Allworth Financial LP now owns 3,209 shares of the company’s stock valued at $46,000 after buying an additional 3,196 shares during the period.
BlackRock Health Sciences Term Trust Price Performance
Shares of NYSE:BMEZ opened at $15.48 on Thursday. BlackRock Health Sciences Term Trust has a 52 week low of $13.67 and a 52 week high of $15.80. The firm has a 50 day moving average of $14.91 and a 200 day moving average of $14.73.
BlackRock Health Sciences Term Trust Announces Dividend
BlackRock Health Sciences Term Trust Company Profile
BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.
The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.
Featured Articles
- Five stocks we like better than BlackRock Health Sciences Term Trust
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
Want to see what other hedge funds are holding BMEZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report).
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.
